<?xml version="1.0" encoding="UTF-8"?>
<p id="par0040">Worldwide health services are presently facing the challenge of COVID-19 pandemic, which is wide spreading rapidly and severely. Health care providers are changing their daily clinical practice in view of the current emergency, and some categories of patients are considered more at risk than others. Patients with cancer have historically been judged at high risk of infections, due to an overall immunocompromised status. However, this connection is not straightforward for CoV infection, both due to the peculiar pathogenesis of CoV in humans and to different mechanisms of action of novel oncologic treatments.</p>
